Metabolic flux analyses to assess the differentiation of adult cardiac progenitors after fatty acid supplementation
Myocardial infarction is the most prevalent of cardiovascular diseases and pharmacological interventions do not lead to restoration of the lost cardiomyocytes. Despite extensive stem cell therapy studies, clinical trials using cardiac progenitor cells have shown moderate results. Furthermore, differ...
Main Authors: | Malandraki-Miller, S, Lopez, C, Alonaizan, R, Purnama, U, Perbellini, F, Pakzad, K, Carr, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2019
|
Similar Items
-
Changing metabolism in differentiating cardiac progenitor cells - can stem cells become metabolically flexible cardiomyocytes?
by: Malandraki-Miller, S, et al.
Published: (2018) -
Substrate metabolism and cardiomyogenic differentiation of cardiac progenitor cells
by: Pakzad, K
Published: (2016) -
Enhancing progenitor cells for cell therapy after myocardial infraction
by: Malandraki-Miller, S
Published: (2016) -
Cardiac regeneration following myocardial infarction: the need for regeneration and a review of cardiac stromal cell populations used for transplantation
by: Alonaizan, R, et al.
Published: (2022) -
Physiological and pharmacological stimulation for in vitro maturation of substrate metabolism in human induced pluripotent stem cell-derived cardiomyocytes
by: Lopez, C, et al.
Published: (2021)